TAT-WLP

General Information


DRACP ID  DRACP06019

Peptide Name   TAT-WLP

Sequence  FSLNWRPPCLFYGRKKRRQRRR

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Targeted peptide conjugates



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C131H210N48O27S

Absent amino acids  ADEHIMTV

Common amino acids  R

Mass  329619

Pl  12.63

Basic residues  9

Acidic residues  0

Hydrophobic residues  5

Net charge  9

Boman Index  -11091

Hydrophobicity  -169.09

Aliphatic Index  35.45

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  6990

Absorbance 280nm  332.86

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN114457052A

Patent Title  Anti-tumor polypeptide composition and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.